By the end of the year, over ** individuals are expected to take part in phase 3 clinical trials for vaccinations against coronavirus. Of the *** trials listed, **** have acquired U.S. taxpayer funding through the Biomedical Advanced Research and Development Authority (BARDA) or "U.S. Project Warp Speed". This statistic shows the number of expected phase 3 participants and BARDA/Warp Speed funding status of selected COVID-19 vaccines, by company, as of July 28, 2020.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Evaluate Vantage. (July 28, 2020). Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 30, 2026, from /statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/
Evaluate Vantage. "Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company." Chart. July 28, 2020. ÌÇÐÄÆƽâ°æ. Accessed July 30, 2026. /statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/
Evaluate Vantage. (2020). Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 30, 2026. /statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/
Evaluate Vantage. "Phase 3 Enrollment and Barda/Warp Speed Funding Status for Select Covid-19 Vaccines, as of July 28, 2020, by Company." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 28 Jul 2020, /statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/
Evaluate Vantage, Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company ÌÇÐÄÆƽâ°æ, /statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/ (last visited July 30, 2026)
Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company [Graph], Evaluate Vantage, July 28, 2020. [Online]. Available: /statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/
